(Q37897691)

English

Amyloid imaging

scientific article published on September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

Amyloid imaging (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

amyloid imaging

0 references

author name string

Victor L Villemagne

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Christopher C Rowe

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

International Psychogeriatrics

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

23 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

S41-9

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Amyloid PET Ligands for Dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Biomarkers for early detection of Alzheimer pathology

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Frequent amyloid deposition without significant cognitive impairment among the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Imaging beta-amyloid burden in aging and dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Mild cognitive impairment: current research and clinical implications

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

[(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000895

21 January 2018

Identifiers

10.1017/S1041610211000895

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37897691&oldid=1733152977"